Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,887 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility and efficacy of enteral tube feeding on weight stability, lean body mass, and patient-reported outcomes in pancreatic cancer cachexia.
Gresham G, Placencio-Hickok VR, Lauzon M, Nguyen T, Kim H, Mehta S, Paski S, Pandol SJ, Osipov A, Gong J, Jamil LH, Nissen N, Lo SK, Hendifar AE. Gresham G, et al. Among authors: mehta s. J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1959-1968. doi: 10.1002/jcsm.12799. Epub 2021 Oct 5. J Cachexia Sarcopenia Muscle. 2021. PMID: 34609081 Free PMC article.
Increasing screening for breast cancer using a randomized evaluation of electronic health record nudges: Design and rationale of the I-screen clinical trial.
Waddell KJ, Mehta SJ, Liao JM, Linn KA, Park S, Rhodes CM, Brophy C, Reitz C, Cousins DS, Williams K, Thatcher EJ, Muskin R, Pronovost PJ, Navathe AS. Waddell KJ, et al. Among authors: mehta sj. Contemp Clin Trials. 2024 Nov 22;148:107753. doi: 10.1016/j.cct.2024.107753. Online ahead of print. Contemp Clin Trials. 2024. PMID: 39581259
Intravenous glibenclamide for cerebral oedema after large hemispheric stroke (CHARM): a phase 3, double-blind, placebo-controlled, randomised trial.
Sheth KN, Albers GW, Saver JL, Campbell BCV, Molyneaux BJ, Hinson HE, Cordonnier C, Steiner T, Toyoda K, Wintermark M, Littauer R, Collins J, Lucas N, Nogueira RG, Simard JM, Wald M, Dawson K, Kimberly WT; CHARM Trial investigators. Sheth KN, et al. Lancet Neurol. 2024 Dec;23(12):1205-1213. doi: 10.1016/S1474-4422(24)00425-3. Lancet Neurol. 2024. PMID: 39577921 Clinical Trial.
An International Factorial Vignette-Based Survey of Intubation Decisions in Acute Hypoxemic Respiratory Failure.
Yarnell CJ, Paranthaman A, Reardon P, Angriman F, Bassi T, Bellani G, Brochard L, De Grooth HJ, Dragoi L, Gaus S, Glover P, Goligher EC, Lewis K, Li B, Kareemi H, Tirupakuzhi Vijayaraghavan BK, Mehta S, Mellado-Artigas R, Moore J, Morris I, Roman-Sarita G, Pham T, Sereeyotin J, Tomlinson G, Wozniak H, Yoshida T, Fowler R; Canadian Critical Care Trials Group. Yarnell CJ, et al. Among authors: mehta s. Crit Care Med. 2024 Nov 22. doi: 10.1097/CCM.0000000000006494. Online ahead of print. Crit Care Med. 2024. PMID: 39576153
A precision randomized trial to evaluate the impact of tailored hepatitis C treatment adherence support on HCV treatment outcomes among people who inject drugs in India: Design and Baseline Characteristics of the STOP-C Trial.
Mehta SH, Lau BM, Ehrhardt S, McFall A, Gunaratne MP, Baishya J, Kedar A, Srikrishnan AK, Evans J, Loeb T, Pradeep A, Kumar MS, Thomas DL, Lucas GM, Solomon SS. Mehta SH, et al. Am J Epidemiol. 2024 Nov 8:kwae430. doi: 10.1093/aje/kwae430. Online ahead of print. Am J Epidemiol. 2024. PMID: 39572371
6,887 results